Patents by Inventor Carsten Möller

Carsten Möller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8053426
    Abstract: The present invention relates to progesterone receptor antagonists of general formula I: in which R1 can be a hydrogen atom and R2 a hydroxyl group or R1 and R2 together can be an oxo group.
    Type: Grant
    Filed: November 15, 2007
    Date of Patent: November 8, 2011
    Assignee: Bayer Schering Pharma AG
    Inventors: Ulrike Fuhrmann, Anja Schmidt, Arwed Cleve, Orlin Petrov, Gunnar Garke, Stefan Pruehs, Margarete Brudny-Kloeppel, Antje Rottmann, Rainer Hasselmann, Marcus Schultze-Mosgau, Carsten Moeller
  • Patent number: 7951790
    Abstract: The present invention relates to progesterone receptor antagonists of general formula I: in which R1 can be a hydrogen atom and R2 a hydroxyl group or R1 and R2 together can be an oxo group.
    Type: Grant
    Filed: November 15, 2007
    Date of Patent: May 31, 2011
    Assignee: Bayer Schering Pharma AG
    Inventors: Ulrike Fuhrmann, Anja Schmidt, Arwed Cleve, Orlin Petrov, Gunnar Garke, Stefan Pruehs, Margarete Brudny-Kloeppel, Antje Rottmann, Rainer Hasselmann, Marcus Schultze-Mosgau, Carsten Moeller
  • Publication number: 20110112057
    Abstract: The present invention relates to treatment regimes and combination products of 20,20,21,21,21-pentafluoro-17-hydroxy-11?-[4-(hydroxyacetyl)phenyl]-19-nor-17?-pregna-4,9-dien-3-one of the formula This invention relates in particular to sequential regimes for the treatment of gynaecological disorders in which the abovementioned progesterone antagonist is administered in a first phase, and a progestogen is administered in a second phase.
    Type: Application
    Filed: May 7, 2009
    Publication date: May 12, 2011
    Applicant: BAYER SCHERING PHARIMA AKTIENGESELL SCHAFT
    Inventors: Ulrike Fuhrmann, Wolfgang Schwede, Carsten Möller
  • Patent number: 7902178
    Abstract: The present invention relates to progesterone receptor antagonists of general formula I: in which R1 can be a hydrogen atom and R2 a hydroxyl group or R1 and R2 together can be an oxo group.
    Type: Grant
    Filed: November 15, 2007
    Date of Patent: March 8, 2011
    Assignee: Bayer Schering Pharma AG
    Inventors: Ulrike Fuhrmann, Anja Schmidt, Arwed Cleve, Orlin Petrov, Gunnar Garke, Stefan Pruehs, Margarete Brudny-Kloeppel, Antje Rottmann, Rainer Hasselmann, Marcus Schultze-Mosgau, Carsten Moeller
  • Publication number: 20110003778
    Abstract: The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometriosis which has a more favorable activity and side-effect profile than treatment therapies currently available. Using a mineralocorticoid receptor antagonist, it is possible to threat endometriosis permanently without any loss of bone mass.
    Type: Application
    Filed: February 28, 2008
    Publication date: January 6, 2011
    Applicant: Bayer Schering Pharma Aktiengesellschaft
    Inventors: Carsten Moeller, Ulrike Kaufmann-Reiche, Anja Schmidt, Ulrike Fuhrmann, Oliver-Martin Fischer
  • Publication number: 20090270381
    Abstract: The present invention relates to non-steroidal progesterone receptor modulators of the general formula I, the use of the progesterone receptor modulators for the manufacture of medicaments, and pharmaceutical compositions which comprise these compounds. The compounds according to the invention are suitable for the therapy and prophylaxis of gynecological disorders such as endometriosis, leiomyomas of the uterus, dysfunctional bleeding and dysmenorrhoea, and for the therapy and prophylaxis of hormone-dependent tumours and for use for female fertility control and for hormone replacement therapy.
    Type: Application
    Filed: December 12, 2008
    Publication date: October 29, 2009
    Inventors: Wolfgang SCHWEDE, Thomas Andrew Kirkland, Carsten Moeller, Stefan Baeurle, Ralf Wyrwa, Andrea Rotgeri
  • Publication number: 20090099147
    Abstract: The present invention relates to non-steroidal progesterone receptor modulators of the general formula I the use of the progesterone receptor modulators for producing medicaments, and pharmaceutical compositions which comprise these compounds. The compounds according to the invention are suitable for the therapy and prophylaxis of gynaecological disorders such as endometriosis, leiomyomas of the uterus, dysfunctional bleeding and dysmenorrhoea, and for the therapy and prophylaxis of hormone-dependent tumours and for use for female fertility control and for hormone replacement therapy.
    Type: Application
    Filed: July 9, 2008
    Publication date: April 16, 2009
    Inventors: Wolfgnag SCHWEDE, Carsten Moeller, Anja Schmidt, Ulrike Fuhrmann, Andrea Rotgeri, Thomas Kirkland
  • Publication number: 20090075989
    Abstract: The present invention relates to non-steroidal progesterone receptor modulators of the general formula 1, the use of the progesterone receptor modulators for the manufacture of medicaments, and pharmaceutical compositions which comprise these compounds. The compounds according to the invention are suitable for the therapy and prophylaxis of gynaecological disorders such as endometriosis, leiomyomas of the uterus, dysfunctional bleeding and dysmenorrhoea, and for the therapy and prophylaxis of hormone-dependent tumours and for use for female fertility control and for hormone replacement therapy.
    Type: Application
    Filed: December 20, 2007
    Publication date: March 19, 2009
    Inventors: Wolfgang Schwede, Carsten Moeller, Anja Schmidt, Ulrike Fuhrmann, Andrea Rotgeri, Thomas Andrew Kirkland, Ralf Wyrwa
  • Publication number: 20080200440
    Abstract: The present invention relates to progesterone receptor antagonists of general formula I: in which R1 can be a hydrogen atom and R2 a hydroxyl group or R1 and R2 together can be an oxo group.
    Type: Application
    Filed: November 15, 2007
    Publication date: August 21, 2008
    Inventors: Ulrike Fuhrmann, Anja Schmidt, Arwed Cleve, Orlin Petrov, Gunnar Garke, Stefan Pruehs, Margarete Brudny-Kloeppel, Antje Rottmann, Rainer Hasselmann, Marcus Schultze-Mosgau, Carsten Moeller
  • Publication number: 20080188448
    Abstract: The present invention relates to non-steroidal progesterone receptor modulators of the general formula I, the use of the progesterone receptor modulators for the manufacture of medicaments, and pharmaceutical compositions which comprise these compounds. The compounds according to the invention are suitable for the therapy and prophylaxis of gynaecological disorders such as endometriosis, leiomyomas of the uterus, dysfunctional bleeding and dysmenorrhoea, and for the therapy and prophylaxis of hormone-dependent tumours and for use for female fertility control and for hormone replacement therapy.
    Type: Application
    Filed: December 20, 2007
    Publication date: August 7, 2008
    Inventors: Wolfgang Schwede, Thomas Andrew Kirkland, Anja Schmidt, Ulrike Fuhrmann, Carsten Moeller, Andrea Rotgeri
  • Patent number: 7408060
    Abstract: This invention relates to nonsteroidal progesterone receptor modulators of general formula I, a process for their production, the use of progesterone receptor modulators for the production of pharmaceutical agents as well as pharmaceutical compositions that contain these compounds. The compounds according to the invention are suitable for therapy and prophylaxis of gynecological diseases, such as endometriosis, leiomyomas of the uterus, dysfunctional bleeding and dysmenorrhea, as well as for the therapy and prophylaxis of hormone-dependent tumors and for use for female birth control as well as for hormone replacement therapy.
    Type: Grant
    Filed: June 23, 2006
    Date of Patent: August 5, 2008
    Assignee: Schering AG
    Inventors: Norbert Schmees, Ulrich Bothe, Wolfgang Schwede, Carsten Moeller, Ulrike Fuhrmann, Anja Schmidt
  • Publication number: 20070142464
    Abstract: This invention relates to nonsteroidal progesterone receptor modulators of general formula I, a process for their production, the use of progesterone receptor modulators for the production of pharmaceutical agents as well as pharmaceutical compositions that contain these compounds. The compounds according to the invention are suitable for therapy and prophylaxis of gynecological diseases, such as endometriosis, leiomyomas of the uterus, dysfunctional bleeding and dysmenorrhea, as well as for the therapy and prophylaxis of hormone-dependent tumors and for use for female birth control as well as for hormone replacement therapy.
    Type: Application
    Filed: June 23, 2006
    Publication date: June 21, 2007
    Inventors: Norbert Schmees, Ulrich Bothe, Wolfgang Schwede, Carsten Moeller, Ulrike Fuhrmann, Anja Schmidt
  • Publication number: 20070010514
    Abstract: The present invention relates to non-steroidal progesterone receptor modulators of the general formula I, a process for their preparation, the use of the progesterone receptor modulators for producing medicaments, and pharmaceutical compositions comprising these compounds. The compounds according to the invention are suitable for the therapy and prophylaxis of gynaecological disorders such as endometriosis, leiomyomas of the uterus, dysfunctional bleeding and dysmenorrhoea, and for the therapy and prophylaxis of hormone-dependent tumours and for use for female fertility control and for hormone replacement therapy.
    Type: Application
    Filed: June 23, 2006
    Publication date: January 11, 2007
    Inventors: Ulrich Bothe, Alexander Hillisch, Peter Droescher, Gunter Kaufmann, Lothar Sobek, Ulrike Fuhrmann, Norbert Schmees, Wolfgang Schwede, Carsten Moeller
  • Publication number: 20060293317
    Abstract: The present invention relates to the use of non-steroidal progesterone receptor modulators of the general formula (I) for the therapy and prophylaxis of gynaecological disorders and of hormone-dependent tumours, and for use for female fertility control and for hormone replacement therapy.
    Type: Application
    Filed: June 23, 2006
    Publication date: December 28, 2006
    Inventors: Norbert Schmees, Wolfgang Schwede, Ulrike Fuhrmann, Anja Schmidt, Carsten Moeller
  • Patent number: 6850139
    Abstract: The invention relates to a system for pulse magnetizing high-precision magnetic scales. The system comprises a shaped current conductor (1) and a pulse current source (2) that is composed of a capacitor bank (3), a transfer switch (4) and a control unit (5). The compact set-up of the system is the prerequisite for a power circuit that has such a low resistance that the required high pulse currents are obtained at supply voltages of below 60 V. The transfer switch is an H bridge with four switches (7) that contain equal numbers of MOS transistors connected in parallel. The short pulse times that are achieved using the MOS transistors allow the use of shaped current conductors with which magnetized areas can be produced with a very high precision. The inventive system provides a means for saving components, electric power and time by a factor of up to 100.
    Type: Grant
    Filed: March 3, 2000
    Date of Patent: February 1, 2005
    Assignee: Imo Institut fur Mikrostrukturtechnologie und Optoelektronik E.V.
    Inventors: Fritz Dettmann, Uwe Loreit, Carsten Möller, Torsten Schönbach
  • Patent number: 5931375
    Abstract: Energy exchanger valve (8) with thermostat valve (12), a housing (9) with inlet (20) and outlet (21), a thermostat bellows displaceable spindle (30) with seal (42) which, by the expansion/contraction of the thermostat bellows and against the pressure of a surrounding spring (31) can close/open an opening (27) with a seating (27a) in a transverse wall (24) between the inlet (20) and the outlet (21), and a piston (13) controlled by differential pressure for the control of a medium's differential pressure across a pre-setting (11) and a thermostat valve (12) consisting of the seating (27a) and the seal (42) between the inlet (20) and the piston (13), the thermostat valve (12) being able to cut off the flow between the inlet and the outlet independently of the pre-setting (11). With the valve (8), only a predetermined maximum amount of the energy-carrying medium flows through the energy exchangers (5).
    Type: Grant
    Filed: March 21, 1997
    Date of Patent: August 3, 1999
    Assignee: Frese Armatur A/S
    Inventors: Hans Henrik Gylov, Ole Joergensen, Carsten Moeller
  • Patent number: 5860591
    Abstract: Energy exchanger, valve (8) with thermostat valve (12), a housing (9) with inlet (15) and outlet (16), a thermostat bellows displaceable spindle (42) with a seal (32) which, against the pressure of a spring (43) surrounding the spindle (42), closes/opens an opening (28) in a transverse wall (29) in the housing (9) between the inlet (15) and the outlet (16), and a membrane (17, 21) controlled by the differential pressure for the control of an energy-carrying medium between the inlet (15) and the outlet (16), and an adjustable closing element (11) between the inlet (15) and the membrane (17, 21), the thermostat valve (12) being able to shut off the flow between the inlet (15) and the outlet (16) independently of the closing element (11). With the valve (8), only a predetermined maximum amount of the medium flows through the energy exchangers (5). If the differential pressure increases upon the closing of one or more valves on a pipe length, the flow in the individual energy exchanger (5) is not increased.
    Type: Grant
    Filed: March 21, 1997
    Date of Patent: January 19, 1999
    Assignee: Frese Armatur A/S
    Inventors: Hans Henrik Gylov, Ole Joergensen, Carsten Moeller